Chronic Myelogenous Leukemia (CML)
Also known as: Chronic Myelogenous Leukemia / Chronic Myeloid Leukemia / Chronic Myeloid Leukaemia / Chronic Myelocytic Leukemia / Chronic Myelogenous Leukaemia / Chronic Myeloid Leukemia (CML) / Chronic Chronic Myelogenous Leukemia / Myeloid leukemia, chronic / Chronic Leukemia, Myeloid / Chronic myeloid leukemia, BCR/ABL-positive / Chronic myeloid leukemia (morphologic abnormality) / Chronic myeloid leukemia, disease (disorder) / Chronic myelogenous leukemia, no ICD-O subtype (morphologic abnormality) / CML / Chronic myelocytic leukaemia / Leukemia myelocytic chronic / Leukaemia myelocytic chronic / Chronic granulocytic leukemia / Leukaemias chronic myeloid / Chronic granulocytic leukaemia / Myeloid leukaemia, chronic / Chronic myeloid leukemia NOS (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB01008 | Busulfan | An alkylating agent used to treat chronic myelogenous leukemia. |
DB00531 | Cyclophosphamide | A nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. |
DB01005 | Hydroxyurea | An antimetabolite used to treat sickle cell anemia crisis, resistant chronic myeloid leukemia, and Locally advanced squamous cell carcinomas of the head and neck (excluding the lip). |
DB00034 | Interferon alfa-2a | A form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. |